课题基金 / 基金详情

Necrotizing Enterocolitis Research Program: introducing innovative therapies to halt the disease progression and promote recovery

Necrotizing Enterocolitis Research Program: introducing innovative therapies to halt the disease progression and promote recovery
坏死性小肠结肠炎研究计划:引入创新疗法来阻止疾病进展并促进康复
批准号:
333730
负责人:
Pierro Agostino
金额:
$264.98万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2015
资助国家:
加拿大
项目状态:
已结题
起止时间:
2015-09-01 至 2022-09-01

项目摘要

项目成果

Pierro Agostino的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Necrotizing enterocolitis (NEC) is the most serious intestinal disease among newborn babies, mostly those who are born prematurely. NEC happens when intestinal tissue becomes damaged and begins to die, but what causes this damage is not yet clear. Right n
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Delivery of nucleic acids using lipid nanoparticles to counteract intestinal injury during necrotizing enterocolitis
  • 批准号:
    478751
  • 项目类别:
    Operating Grants
  • 资助金额:
    $74.07万
  • 财政年份:
    2023
  • 负责人:
    Pierro Agostino
  • 依托单位:
Hormonal modulation of the gut-brain axis in necrotizing enterocolitis
  • 批准号:
    469489
  • 项目类别:
    Operating Grants
  • 资助金额:
    $60.19万
  • 财政年份:
    2022
  • 负责人:
    Pierro Agostino
  • 依托单位:
海外基金